中华眼底病杂志
中華眼底病雜誌
중화안저병잡지
CHINESE JOURNAL OF OCULAR FUNDUS DISEASES
2012年
6期
621-624
,共4页
张社德%张天峰%罗荣%钟秀华
張社德%張天峰%囉榮%鐘秀華
장사덕%장천봉%라영%종수화
曲安奈德/治疗应用%激光凝固术/治疗应用%黄斑水肿/治疗%Meta分析
麯安奈德/治療應用%激光凝固術/治療應用%黃斑水腫/治療%Meta分析
곡안내덕/치료응용%격광응고술/치료응용%황반수종/치료%Meta분석
Triamcinolone acetonide/therapeutic uses%Laser coagulation/therapeutic uses%Macula edema/therapy%Meta-analysis
目的 比较单纯黄斑区格栅样激光光凝(MLG)与玻璃体腔注射曲安奈德(IVTA)联合MLG治疗糖尿病黄斑水肿(DME)的有效性及安全性.方法 计算机检索循证医学图书馆、荷兰医学文摘、生物医学数据库、中国生物医学文献数据库、中国期刊全文数据库及中文科技期刊全文数据库.收集IVTA联合MLG与MLG治疗DME临床随机对照试验(RCT),评价纳入研究的质量,提取有效数据,采用荟萃分析软件(RevMan)5.1进行meta分析.比较两种治疗方法对最佳矫正视力(BCVA)及黄斑中心凹厚度(CMT)的影响.结果 共纳入6个RCT,共331只眼.其中,MLG组166只眼,IVTA联合MLG组165只眼.随访6个月时,IVTA联合MLG组与MLG组比较,BCVA差异无统计学意义(Z=1.27,P=0.20),但CMT差异有统计学意义(Z=2.41,P=0.02),眼压增高及白内障等并发症发生率差异有统计学意义(Z=3.62,P<0.01).结论 IVTA联合MLG治疗DME可降低CMT,但在改善视功能方面与MLG比较无明显优势.这仍需要高质量的、大样本的RCT数据进一步论证.
目的 比較單純黃斑區格柵樣激光光凝(MLG)與玻璃體腔註射麯安奈德(IVTA)聯閤MLG治療糖尿病黃斑水腫(DME)的有效性及安全性.方法 計算機檢索循證醫學圖書館、荷蘭醫學文摘、生物醫學數據庫、中國生物醫學文獻數據庫、中國期刊全文數據庫及中文科技期刊全文數據庫.收集IVTA聯閤MLG與MLG治療DME臨床隨機對照試驗(RCT),評價納入研究的質量,提取有效數據,採用薈萃分析軟件(RevMan)5.1進行meta分析.比較兩種治療方法對最佳矯正視力(BCVA)及黃斑中心凹厚度(CMT)的影響.結果 共納入6箇RCT,共331隻眼.其中,MLG組166隻眼,IVTA聯閤MLG組165隻眼.隨訪6箇月時,IVTA聯閤MLG組與MLG組比較,BCVA差異無統計學意義(Z=1.27,P=0.20),但CMT差異有統計學意義(Z=2.41,P=0.02),眼壓增高及白內障等併髮癥髮生率差異有統計學意義(Z=3.62,P<0.01).結論 IVTA聯閤MLG治療DME可降低CMT,但在改善視功能方麵與MLG比較無明顯優勢.這仍需要高質量的、大樣本的RCT數據進一步論證.
목적 비교단순황반구격책양격광광응(MLG)여파리체강주사곡안내덕(IVTA)연합MLG치료당뇨병황반수종(DME)적유효성급안전성.방법 계산궤검색순증의학도서관、하란의학문적、생물의학수거고、중국생물의학문헌수거고、중국기간전문수거고급중문과기기간전문수거고.수집IVTA연합MLG여MLG치료DME림상수궤대조시험(RCT),평개납입연구적질량,제취유효수거,채용회췌분석연건(RevMan)5.1진행meta분석.비교량충치료방법대최가교정시력(BCVA)급황반중심요후도(CMT)적영향.결과 공납입6개RCT,공331지안.기중,MLG조166지안,IVTA연합MLG조165지안.수방6개월시,IVTA연합MLG조여MLG조비교,BCVA차이무통계학의의(Z=1.27,P=0.20),단CMT차이유통계학의의(Z=2.41,P=0.02),안압증고급백내장등병발증발생솔차이유통계학의의(Z=3.62,P<0.01).결론 IVTA연합MLG치료DME가강저CMT,단재개선시공능방면여MLG비교무명현우세.저잉수요고질량적、대양본적RCT수거진일보론증.
Objective To evaluate the efficacy and safety of intravitreal triamcinolone acetonide combined of macular laser grid photocoagulation (IVTA/MLG) versus macular laser grid (MLG)photocoagulation only for treatment of diabetic macular edema.Methods A computerized search was conducted in the Cochrane Library, Embase Library, Pubmed,Chinese Biomedical Database,Chinese Journal Full-text Database and Chinese Science and Technology Periodicals Database.Randomized controlled trials (RCT) on IVTA/MLG and MLG only for treatment of diabetic macular edema were selected.After the data extraction,quality of RCT was assessed.The meta analysis was performed by RevMan 5.1.The outcome measures included best-corrected visual acuity (BCVA) and the central foveal thickness (CMT).Results In total,six RCT that fulfilled the eligibility criteria were included in the meta-analysis involving 166 eyes in MLG group and 165 eyes in IVTA/MLG group.The results suggested that there was no significant differences in BCVA (Z =1.27,P =0.20 ), but differences were statistically significant comparing CMT (Z=2.41,P=0.02),incidence of ocular hypertension and cataract (Z=3.62,P<0.01)between MLG and IVTA/MLG groups at the six month follow-up.Conclusions There is no significant advantage of IVTA/MLG as compared with MLG,but it could reduce CMT.However,a high-quality,large sample RCT should be further investigated.